Cargando…
Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats
BACKGROUND: Recent studies revealed that erythropoietin (EPO) has tissue-protective effects in the heart by increasing vascular endothelial growth factor (VEGF) expression and attenuating myocardial fibrosis in ischemia models. In this study, we investigated the effect of EPO on ventricular remodeli...
Autores principales: | Lu, Jing, Yao, Yu-yu, Dai, Qi-ming, Ma, Gen-shan, Zhang, Shu-feng, Cao, Lei, Ren, Li-qun, Liu, Nai-feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527329/ https://www.ncbi.nlm.nih.gov/pubmed/22954171 http://dx.doi.org/10.1186/1475-2840-11-105 |
Ejemplares similares
-
Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats
por: Bi, Fangjie, et al.
Publicado: (2018) -
Rutin administration attenuates myocardial dysfunction in diabetic rats
por: Guimaraes, Julliano F C, et al.
Publicado: (2015) -
Ivabradine promotes angiogenesis and reduces cardiac hypertrophy in mice with myocardial infarction
por: Wu, Xiangqi, et al.
Publicado: (2018) -
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012) -
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
por: Li, Chenguang, et al.
Publicado: (2019)